Spermidine/spermine N1-acetyltransferase-1 as a diagnostic biomarker in human cancer

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Global cancer facts & figures (2018). www.cancer.org/research/cancer-facts-statistics/global.html.
  Google Scholar
• 2 Canadian Cancer Society. Canadian cancer statistics publication (2018). http://www.cancer.ca/en/cancer-information/cancer-101/canadian-cancer-statistics-publication/?region=on.
  Google Scholar
• 3 Pegg AE. Functions of polyamines in mammals. J. Biol. Chem. 291(29), 14904–14912 (2016).
  Medline CASGoogle Scholar
• 4 Pegg AE. Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator. Am. J. Physiol. Endocrinol. Metab. 294(6), E995–E1010 (2008). •• An excellent and comprehensive review of the cellular function of spermidine/spermine N1-acetyl transferase (SSAT).
  Medline CASGoogle Scholar
• 5 Babbar N, Hacker A, Huang Y, Casero RA. Tumor necrosis factor α induces spermidine/spermine N1-acetyltransferase through nuclear factor κB in non-small-cell lung cancer cells. J. Biol. Chem. 281(34), 24182–24192 (2006). •• An important discovery demonstrating that a common mediator of inflammation can lead to the induction of SSAT expression by activating the NF-κB signaling pathway in non-small-cell lung cancer cells.
  Medline CASGoogle Scholar
• 6 Gabrielson E, Tully E, Hacker A et al. Induction of spermidine/spermine N1-acetyltransferase in breast cancer tissues treated with the polyamine analogue N1,N11-diethylnorspermine. Cancer Chemother. Pharmacol. 54(2), 122–126 (2004).
  Medline CASGoogle Scholar
• 7 Huang W, Eickhoff JC, Mehraein-Ghomi F et al. Expression of spermidine/spermine N1-acetyl transferase (SSAT) in human prostate tissues is related to prostate cancer progression and metastasis. Prostate 75(11), 1150–1159 (2015).
  Medline CASGoogle Scholar
• 8 Bras AP, Hoff HR, Aoki FY, Sitar DS. Amantadine acetylation may be effected by acetyltransferases other than NAT1 or NAT2. Can. J. Physiol. Pharmacol. 76(7–8), 701–706 (1998). •• First demonstration that amantadine is acetylated in humans by another acetyltransferase enzyme that is neither linked to N-acetyl transferase 1 nor to N-acetyl transferase 2.
  Medline CASGoogle Scholar
• 9 Bras APM, Jänne J, Porter CW, Sitar DS. Spermidine/spermine N1-acetyltransferase catalyzes amantadine acetylation. Drug Metab. Dispos. 29(5), 676–680 (2001). •• Provides evidence that amantadine can be acetylated by SSAT and that it may be a specific drug substrate for this enzyme.
  Medline CASGoogle Scholar
• 10 Matsui I, Wiegand L, Pegg AE. Properties of spermidine N-acetyltransferase from livers of rats treated with carbon tetrachloride and its role in the conversion of spermidine into putrescine. J. Biol. Chem. 256(5), 2454–2459 (1981).
  Medline CASGoogle Scholar
• 11 Pegg AE, Seely JE, Pösö H, della Ragione F, Zagon IA. Polyamine biosynthesis and interconversion in rodent tissues. Fed. Proc. 41(14), 3065–3072 (1982).
  Medline CASGoogle Scholar
• 12 Seiler N. Functions of polyamine acetylation. Can. J. Physiol. Pharmacol. 65(10), 2024–2035 (1987).
  Medline CASGoogle Scholar
• 13 Bettuzzi S, Davalli P, Astancolle S et al. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. Cancer Res. 60(1), 28–34 (2000).
  Medline CASGoogle Scholar
• 14 Russell DH. Increased polyamine concentrations in the urine of human cancer patients. Nature New Biol. 233(39), 144–145 (1971).
  Medline CASGoogle Scholar
• 15 Suh JW, Lee SH, Chung BC, Park J. Urinary polyamine evaluation for effective diagnosis of various cancers. J. Chromatogr. B Biomed. Sci. Appl. 688(2), 179–186 (1997).
  Medline CASGoogle Scholar
• 16 Takenoshita S, Matsuzaki S, Nakano G et al. Selective elevation of the N1-acetylspermidine level in human colorectal adenocarcinomas. Cancer Res. 44(2), 845–847 (1984).
  Medline CASGoogle Scholar
• 17 Kingsnorth AN, Wallace HM. Elevation of monoacetylated polyamines in human breast cancers. Eur. J. Cancer Clin. Oncol. 21(9), 1057–1062 (1985).
  Medline CASGoogle Scholar
• 18 Pine M, Huben R, Pegg A. Production of N1-acetyl spermidine by renal cell tumors. J. Urol. 141(3), 651–655 (1989).
  Medline CASGoogle Scholar
• 19 Sessa A, Perin A. Increased synthesis of N1-acetylspermidine in hepatic preneoplastic nodules and hepatomas. Cancer Lett. 56(2), 159–163 (1991).
  Medline CASGoogle Scholar
• 20 Hyvönen T, Keinänen TA, Khomutov AR, Khomutov RM, Eloranta TO. Monitoring of the uptake and metabolism of aminooxy analogues of polyamines in cultured cells by high-performance liquid chromatography. J. Chromatogr. 574(1), 17–21 (1992).
  Medline CASGoogle Scholar
• 21 Lou G, Zhang M, Minuk GY. Effects of acute ethanol exposure on polyamine and gamma-aminobutyric acid metabolism in the regenerating liver. Alcohol 19(3), 219–227 (1999).
  Medline CASGoogle Scholar
• 22 Dilman VM, Anisimov VN, Kolosov AI, Bulovskaya LN. On the relationship between the activity of acetylation, growth of experimental tumors and efficacy of their suppression by hydrazine sulphate. Oncology 33(5–6), 219–221 (1976).
  Medline CASGoogle Scholar
• 23 Bulovskaya LN, Krupkin RG, Bochina TA, Shipkova AA, Pavlova MV. Acetylator phenotype in patients with breast cancer. Oncology 35(4), 185–188 (1978).
  Medline CASGoogle Scholar
• 24 Chekharina Y, Bulovskaya LN, Pavlova MV, Krupkin RG. Activity of N-acetyltransferase in patients with malignant lymphomas. Neoplasma 25(4), 471–475 (1978).
  Medline CASGoogle Scholar
• 25 Geylan YS, Dizbay S, Güray T. Arylamine N-acetyltransferase activities in human breast cancer tissues. Neoplasma 48(2), 108–111 (2001).
  Medline CASGoogle Scholar
• 26 Estrada-Rodgers L, Levy GN, Weber WW. Characterization of a hormone response element in the mouse N-acetyltransferase 2 (Nat2*) promoter. Gene Expr. 7(1), 13–24 (1998).
  Medline CASGoogle Scholar
• 27 Bhardwaj M, Erben V, Schrotz-King P, Brenner H. Cell line secretome and tumor proteome markers for early detection of colorectal cancer: a systematic review. Cancers 9(11), 156 (2017). • In this review the results of studies evaluating markers derived from the secretome and tumor proteome for blood-based early detection of colorectal cancer are summarized.
  Google Scholar
• 28 Moertel CG, Fleming TR, Macdonald JS et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270(8), 943–947 (1993).
  Medline CASGoogle Scholar
• 29 Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest. 23(4), 338–351 (2005).
  MedlineGoogle Scholar
• 30 Mroczko B, Groblewska M, Wereszczynska-Siemiatkowska U et al. The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients. Clin. Chim. Acta 371(1–2), 143–147 (2006).
  Medline CASGoogle Scholar
• 31 Gonzalez-Pons M, Cruz-Correa M. Colorectal cancer biomarkers: where are we now. Biomed. Res. Int. 2015, 149014 (2015).
  MedlineGoogle Scholar
• 32 Zhang SY, Lin M, Zhang HB. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19–9 for colorectal carcinoma. Int. J. Clin. Exp. Pathol. 8(8), 9404–9409 (2015).
  Medline CASGoogle Scholar
• 33 Cartlidge CR, MRA U, Alkhatib AMA, Taylor-Robinson SD. The utility of biomarkers in hepatocellular carcinoma: review of urine-based ¹H-NMR studies-what the clinician needs to know. Int. J. Gen. Med. 10, 431–442 (2017).
  Medline CASGoogle Scholar
• 34 Farinati F, Marino D, De Giorgio M et al. Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma: both or neither? Am. J. Gastroenterol. 101(3), 524–532 (2006).
  Medline CASGoogle Scholar
• 35 Aoki FY, Sitar DS. Clinical pharmacokinetics of amantadine hydrochloride. Clin. Pharmacokinet. 14(1), 35–51 (1988). • A comprehensive account on the pharmacology and pharmacokinetics of amantadine.
  Medline CASGoogle Scholar
• 36 Gaudry SE, Sitar DS, Smyth DD, McKenzie JK, Aoki FY. Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine. Clin. Pharmacol. Ther. 54(1), 23–27 (1993). • Interesting study examining the influence of sex and age on the renal clearance of amantadine.
  Medline CASGoogle Scholar
• 37 Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics 1, 239–259 (2009).
  Medline CASGoogle Scholar
• 38 Neidhart M. DNA methylation and epigenetic biomarkers in non-neoplastic diseases. In: DNA Methylation and Complex Human Disease. Academic Press, Cambridge, MA, USA, 29–43 (2015).
  Google Scholar
• 39 Kang YP, Ward NP, DeNicola GM. Recent advances in cancer metabolism: a technological perspective. Exp. Mol. Med. 50(4), 31 (2018).
  MedlineGoogle Scholar
• 40 Martín-Martín N, Carracedo A, Torrano V. Metabolism and transcription in cancer: merging two classic tales. Front. Cell. Dev. Biol. 5, 119 (2017).
  MedlineGoogle Scholar
• 41 Singh D, Arora R, Kaur P et al. Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer. Cell Biosci. 7, 62 (2017).
  Medline CASGoogle Scholar
• 42 Patel S, Ahmed S. Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery. J. Pharm. Biomed. Anal. 107, 63–74 (2015). •• An excellent review that discusses the efficacy of metabolomics in identifying biomarkers associated with diagnosis, prognosis and treatment of cancer.
  Medline CASGoogle Scholar